=EFFICACY AND SAFETY OF BOCOCIZUMAB (RN316/PF-04950615), A MONOCLONAL ANTIBODY AGAINST PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 IN STATIN-TREATED HYPERCHOLESTEROLEMIC SUBJECTS: RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING STUDY (NCT: 01592240)

✍ Scribed by Ballantyne, Christie M.; Neutel, Joel; Cropp, Anne; Duggan, William; Wang, Ellen; Plowchalk, David; Sweeney, Kevin; Kaila, Nitin; Vincent, John; Bays, Harold

• Book ID: 122260978
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 182 KB
• Volume: 63
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/S0735-1097(14)61374-7